NASDAQ:OMED »

  • Business » OncoMed Roars on Partnership News
    December 4, 2013, 07:19 GMT

    The biotechnology space has been a hot bed for investment over the last year as investors searched for undervalued growth in a market at all time highs. Many familiar names including Gilead, Celegene (NASDAQ:CELG) , and Amgen (NASDAQ:AMGN) have roared higher on strong pipeline data and acquisition. However, in recent weeks, some of the smaller, higher